Codexis to Participate in Two Virtual Investment Conferences
REDWOOD CITY, Calif., May 27, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]
ADMA Biologics to Participate in Jefferies Virtual Healthcare Conference
RAMSEY, N.J. and BOCA RATON, Fla., May 27, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]
NuCana to Present at the 2020 Jefferies Virtual Healthcare Conference
EDINBURGH, United Kingdom, May 27, 2020 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced today that Hugh Griffith, Chief Executive […]
FibroGen to Present at Upcoming Investor Conferences
SAN FRANCISCO, May 27, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, […]
CareDx Presents the Latest AlloSure Data in Virtual Meetings
SOUTH SAN FRANCISCO, Calif., May 27, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
RedHill Biopharma Provides Q1/2020 Financial Results and Recent Highlights Including Initial Movantik® Revenues
Completed acquisition of Movantik® from AstraZeneca on April 1, 2020, and initiated U.S. promotion with net revenues of $7.3 million […]
Orchard Therapeutics to Present at Virtual Investor Conferences in June
BOSTON and LONDON, May 27, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced […]
ZAGG to Report First Quarter 2020 Results on May 28, 2020
SALT LAKE CITY, May 27, 2020 (GLOBE NEWSWIRE) — ZAGG Inc (Nasdaq: ZAGG), a leading global mobile lifestyle company, will […]
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
EWING, N.J., May 27, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President […]
Zynerba Pharmaceuticals Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in Autism Spectrum Disorder
– The BRIGHT Trial Achieved Statistically Significant and Clinically Meaningful Improvements from Baseline in All Subscales of the Aberrant Behavior […]
